Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nutra Pharma's free cash flow for the twelve months ending Dec 31, 2025 was -$1.19M. For fiscal 2025 it was -$1.19M. The highest annual figure on record is -$169.68K in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.19M | – |
| FY2022 | Dec 31, 2022 | -$820.43K | – |
| FY2021 | Dec 31, 2021 | -$1.78M | – |
| FY2020 | Dec 31, 2020 | -$883.99K | – |
| FY2017 | Dec 31, 2017 | -$1.15M | – |
| FY2016 | Dec 31, 2016 | -$1.36M | – |
| FY2015 | Dec 31, 2015 | -$1.02M | – |
| FY2014 | Dec 31, 2014 | -$169.68K | – |
| FY2012 | Dec 31, 2012 | -$721.24K | – |
| FY2011 | Dec 31, 2011 | -$1.89M | – |
| FY2010 | Dec 31, 2010 | -$1.43M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$219.82K | – |
| Q3 FY2025 | Sep 30, 2025 | -$250.77K | – |
| Q2 FY2025 | Jun 30, 2025 | -$288.37K | – |
| Q1 FY2025 | Mar 31, 2025 | -$431.06K | – |
| Q4 FY2022 | Dec 31, 2022 | -$54.03K | – |
| Q3 FY2022 | Sep 30, 2022 | -$165.34K | – |
| Q2 FY2022 | Jun 30, 2022 | -$284.83K | – |
| Q1 FY2022 | Mar 31, 2022 | -$316.23K | – |
| Q4 FY2021 | Dec 31, 2021 | -$237.96K | – |
| Q3 FY2021 | Sep 30, 2021 | -$417.52K | – |
| Q2 FY2021 | Jun 30, 2021 | -$523.75K | – |
| Q1 FY2021 | Mar 31, 2021 | -$604.28K | – |
See a number that looks wrong?